Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections
NEPTUNE
1 other identifier
interventional
300
1 country
2
Brief Summary
The purpose of this study is to determine, in patients who undergo an elective colorectal resection through a midline laparotomy incision, whether the use of negative pressure wound therapy (NPWT) applied to the site of the laparotomy compared to standard care alone, reduces the incidence of surgical site infection (SSI) in the first 30 days postoperatively. The investigators hypothesize that the use of NPWT will reduce the rate of postoperative SSI, as well as decrease the need for Nursing Home Care for SSI, length of hospital stay and return visits related to SSI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2013
CompletedFirst Posted
Study publicly available on registry
December 10, 2013
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedOctober 19, 2018
October 1, 2018
2.2 years
December 5, 2013
October 17, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Surgical Site Infection (SSI)
Postoperative surgical site infection (SSI), as defined by the following CDC (Centre for Disease Control) criteria: Infection occurring within the first 30 post-operative days with at least one of the following: 1. Purulent drainage from the incision 2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the incision 3. At least one of the following signs/symptoms of infection * Pain or tenderness * Localized swelling * Redness * Heat AND incision is deliberately opened by a surgeon (unless incision is culture negative) 4. Diagnosis of SSI by the surgeon or attending physician
30 days following operation
Secondary Outcomes (4)
Need for Home Nursing Care (Home Care) related to Surgical Site Infection (SSI)
Up to 60 days post-operatively to encompass the treatment period required for the SSI.
Length of Stay in Hospital
Up to 60 days post-operatively to encompass the prolonged stay in hospital of some patients
Cost of Management of Surgical Site Infection (SSI)
Up to 60 days post-operatively to include the treatment period encompassed in the outpatient setting
Number of Return Visits Related to Surgical Site Infection
Up to 60 days post-operatively to include the treatment period encompassed in the outpatient setting
Other Outcomes (1)
Potential Harm from PIMS therapy
Within the first 30 post-operative days
Study Arms (2)
Negative Pressure Wound Therapy
EXPERIMENTALThis group will receive the usual care of surgical wound AND Negative Pressure Wound Therapy (NPWT). The Prevena™ Incision Management System (PIMS) is placed in a sterile fashion over the closed surgical site prior to leaving the operating room. The PIMS is to remain in place until the completion of therapy at five days.
Usual Care of Surgical Wound
ACTIVE COMPARATORThis group will receive the usual care of a surgical wound.
Interventions
Prevena™ Incision Management System (PIMS) (Kinetic Concepts Inc. (KCI), San Antonio, TX) is an incisional vacuum assisted closure (PIMS) device intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy The PIMS applies continuous pressure to the closed surgical site at 125 mm Hg and is attached to a 45 mL canister for collection of exudate.
Patients will receive pre-operative antibiotics consisting of 1g cefazolin (or in the case of an allergy, an alternative e.g. ciprofloxacin/vancomycin) and 500 mg metronidazole given intravenously within the 30 minute prior to beginning the operative procedure. In cases extending \> 4 hours, a second dose of each of the antibiotics will be administered. Hair at the operative site will be removed, if required, immediately prior to the skin incision using electric clippers. The abdomen will be prepped using 2% Chlorhexidiene solution (or 10% povidone if allergic). After closure of the skin, the surgical wound will be covered with a sterile adhesive dressing (Tegaderm), which will remain in place until the morning of post-operative day (POD)#2, unless saturated, in which case it is standard practice to change the dressing if the physician is in agreement. On POD#2, the surgical team will remove the initial dressing and daily dressing changes with standard gauze will be initiated.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Planned elective colorectal resection (those that occur as a scheduled operation in the surgeons' planned operative list)
You may not qualify if:
- Palliative colorectal resection where predicted remaining lifespan is likely less than 30 days
- Abdominoperineal resection or pelvic exenteration
- Known allergy/sensitivity to adhesive
- Cases in which there is a suspicion of bowel perforation
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
London Health Sciences Centre - University Campus
London, Ontario, N6A 5A5, Canada
London Health Sciences Centre - Victoria Campus
London, Ontario, N6A 5W9, Canada
Related Publications (2)
Murphy PB, Knowles S, Chadi SA, Vogt K, Brackstone M, Koughnett JAV, Ott MC. Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections (NEPTUNE): A Randomized Controlled Trial. Ann Surg. 2019 Jul;270(1):38-42. doi: 10.1097/SLA.0000000000003111.
PMID: 30499799DERIVEDChadi SA, Vogt KN, Knowles S, Murphy PB, Van Koughnett JA, Brackstone M, Ott MC. Negative pressure wound therapy use to decrease surgical nosocomial events in colorectal resections (NEPTUNE): study protocol for a randomized controlled trial. Trials. 2015 Jul 30;16:322. doi: 10.1186/s13063-015-0817-8.
PMID: 26223227DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Ott, MD, MSc, FRCSC, FACS, FASCRS
Division of General Surgery, Western University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2013
First Posted
December 10, 2013
Study Start
January 1, 2015
Primary Completion
March 6, 2017
Study Completion
September 1, 2017
Last Updated
October 19, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share